Page Not Found
Page not found. Your pixels are in another canvas.
A list of all the posts and pages found on the site. For you robots out there is an XML version available for digesting as well.
Page not found. Your pixels are in another canvas.
About me
This is a page not in th emain menu
Published:
This post will show up by default. To disable scheduling of future posts, edit config.yml
and set future: false
.
Published:
This is a sample blog post. Lorem ipsum I can’t remember the rest of lorem ipsum and don’t have an internet connection right now. Testing testing testing this blog post. Blog posts are cool.
Published:
This is a sample blog post. Lorem ipsum I can’t remember the rest of lorem ipsum and don’t have an internet connection right now. Testing testing testing this blog post. Blog posts are cool.
Published:
This is a sample blog post. Lorem ipsum I can’t remember the rest of lorem ipsum and don’t have an internet connection right now. Testing testing testing this blog post. Blog posts are cool.
Published:
This is a sample blog post. Lorem ipsum I can’t remember the rest of lorem ipsum and don’t have an internet connection right now. Testing testing testing this blog post. Blog posts are cool.
Published in Under review for AISTATS 2025, 2024
Randomized Controlled Trials (RCT) are the current gold standards to empirically measure the effect of a new drug. However, they may be of limited size and resorting to complementary non-randomized data, referred to as observational, is promising, as additional sources of evidence. In both RCT and observational data, the Risk Difference (RD) is often used to characterize the effect of a drug. Additionally, medical guidelines recommend to also report the Risk Ratio (RR), which may provide a different comprehension of the effect of the same drug. While different methods have been proposed and studied to estimate the RD, few methods exist to estimate the RR. In this paper, we propose estimators of the RR both in RCT and observational data and provide both asymptotical and finite-sample analyses. We show that, even in an RCT, estimating treatment allocation probability or adjusting for covariates leads to lower asymptotic variance. In observational studies, we propose weighting and outcome modeling estimators and derive their asymptotic bias and variance for well-specified models. Using semi-parametric theory, we define two doubly robusts estimators with minimal variances among unbiased estimators. We support our theoretical analysis with empirical evaluations and illustrate our findings through experiments.
Download here
Undergraduate course, University 1, Department, 2014
This is a description of a teaching experience. You can use markdown like any other post.